Matching weight-loss treatments to binge eating patterns
Part of Hormones & metabolism clinical trials.
This study tests whether a medication called semaglutide, which is used for weight loss, works better for people who also have binge eating. It aims to find the best treatment based on brain and behavior differences.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your body mass index (BMI) is 30 or higher, or 27 or higher with a weight-related health condition.
- You do not have diabetes.
- You have not had weight-loss surgery.
- You have not used certain weight-loss or diabetes medications in the past 3 months.
- You are willing to undergo brain scans (MRI and possibly PET) as part of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called bofanglutide to see if it helps people with overweight or obesity lose more weight than a standard treatment. It is for adults who have not been able to lose weight with diet and exercise alone.
This early-stage study tests a small implant placed under the skin that releases a weight management medicine (semaglutide) slowly over time. The goal is to see how safe it is and how your body handles it.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study tests whether a weight-loss medication (a GLP-1 agonist) can change how the brain works and help with long-term weight control. It involves brain scans and a closely monitored treatment plan.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.